We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




New Technology That Automates Blood Smears to Help Labs Accurately Diagnose Bloodborne Diseases

By LabMedica International staff writers
Posted on 19 Jan 2022
Print article
Image: Autohaem smear and smear+  (Photo courtesy of Samuel McDermott)
Image: Autohaem smear and smear+ (Photo courtesy of Samuel McDermott)

A team of researchers have developed devices to automate blood smears that can consistently create high-quality smears equivalent to those created by human experts.

The device developed by researchers from Cambridge University (Cambridge, England), Bath University (Bath, UK), and the Ifakara Health Institute (Ifakara, Tanzania) removes one of the biggest bottlenecks preventing quick, reliable malaria diagnosis

One of the key steps in diagnosing or treating many bloodborne diseases is to perform a blood smear, where a drop of blood is spread across a microscope slide for analysis. It is critical the technician collecting the sample perform this smear correctly and consistently, but mistakes at this stage are easy to make and often result in useless samples. The researchers' primary focus is on diagnosis of malaria, a deadly disease that kills more than 400,000 people every year. Malaria is best diagnosed by analyzing blood smears through a microscope. While performing research for a previous study, they noticed many of these testing smears were of poor quality.

Their solution, the autohaem devices, solves this problem by automating the smearing process so every smear is correct and consistent. The devices come in two varieties, the autohaem smear and the autohaem smear+, the latter of which is fully automated with a motorized smearing mechanism. In tests, inexperienced technicians were able to use the device to produce expert-quality smears.

A key goal of the project was to make the autohaem devices accessible to as many people as possible. The researchers designed their devices to be easy to build, using readily available or 3D-printed components. Furthermore, all software and hardware are open-source and freely available. The next step for the researchers is to test out their design in real-world conditions.

"Creating blood smears is a laborious, repetitive task that requires an expert level of skill and manual dexterity," said researcher Samuel McDermott. "By using automated blood smearing machines, such as autohaem devices, technicians will be able to increase their throughput while maintaining a high enough quality for diagnosis."

Related Links:
Cambridge University 
Bath University 
Ifakara Health Institute 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.